litlas
ログインアカウント作成

Shinichi Toyooka

2001–2025 年に発表

141
論文数
20,829
被引用数
71
h 指数
128
i10 指数

被引用数

Shinichi Toyooka の年別被引用数1999 年: 被引用 1 件2001 年: 被引用 23 件2002 年: 被引用 86 件2003 年: 被引用 118 件2004 年: 被引用 150 件2005 年: 被引用 245 件2006 年: 被引用 250 件2007 年: 被引用 244 件2008 年: 被引用 224 件2009 年: 被引用 162 件2010 年: 被引用 222 件2011 年: 被引用 287 件2012 年: 被引用 247 件2013 年: 被引用 291 件2014 年: 被引用 199 件2015 年: 被引用 243 件2016 年: 被引用 178 件2017 年: 被引用 144 件2018 年: 被引用 136 件2019 年: 被引用 498 件2020 年: 被引用 462 件2021 年: 被引用 471 件2022 年: 被引用 355 件2023 年: 被引用 233 件2024 年: 被引用 440 件2025 年: 被引用 222 件2026 年: 被引用 7 件2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,913 件、この内訳の 25.8%中国: 引用元論文 1,075 件、この内訳の 14.5%日本: 引用元論文 778 件、この内訳の 10.5%イギリス: 引用元論文 362 件、この内訳の 4.9%イタリア: 引用元論文 326 件、この内訳の 4.4%ドイツ: 引用元論文 287 件、この内訳の 3.9%韓国: 引用元論文 247 件、この内訳の 3.3%フランス: 引用元論文 235 件、この内訳の 3.2%スペイン: 引用元論文 194 件、この内訳の 2.6%カナダ: 引用元論文 181 件、この内訳の 2.4%台湾: 引用元論文 157 件、この内訳の 2.1%インド: 引用元論文 143 件、この内訳の 1.9%
0%25.8%その他 20.5%

機関

分野

  • Medicine64.8%
  • Biochemistry, Genetics and Molecular Biology31.2%
  • Immunology and Microbiology1.4%
  • Computer Science0.5%
  • Engineering0.5%
  • Neuroscience0.3%
  • その他1.3%

トピック

  • Lung Cancer Treatments and Mutations16.1%
  • Lung Cancer Research Studies6.2%
  • Lung Cancer Diagnosis and Treatment6.1%
  • Epigenetics and DNA Methylation4.5%
  • Cancer Genomics and Diagnostics4.4%
  • HER2/EGFR in Cancer Research3.3%
  • その他59.4%

共著者

全論文

検索で開く
  1. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

    著者: Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Junji Tsurutani, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami, Nobuyuki Katakami, Minoru Takada, Hiroshige Yoshioka, Kazuhiko Shibata, Shinzoh Kudoh, Eiji Shimizu, Hiroshi Saito, Shinichi Toyooka, Kazuhiko Nakagawa, Masahiro Fukuoka - The Lancet Oncology 2009 被引用: 4,114

  2. Immune evasion through mitochondrial transfer in the tumour microenvironment

    著者: Hideki Ikeda, Katsushige Kawase, Tatsuya Nishi, Tomofumi Watanabe, Keizo Takenaga, Takashi Inozume, Takamasa Ishino, Sho Aki, Jason Lin, Shusuke Kawashima, Joji Nagasaki, Youki Ueda, Shinichiro Suzuki, Hideki Makinoshima, Makiko Itami, Yuki Nakamura, Yasutoshi Tatsumi, Yusuke Suenaga, Takao Morinaga, Akiko Honobe‐Tabuchi, Takehiro Ohnuma, Tatsuyoshi Kawamura, Yoshiyasu Umeda, Yasuhiro Nakamura, Yukiko Kiniwa, Eiki Ichihara, Hidetoshi Hayashi, Jun‐ichiro Ikeda, Toyoyuki Hanazawa, Shinichi Toyooka, Hiroyuki Mano, Takuji Suzuki, Tsuyoshi Osawa, Masahito Kawazu, Yosuke Togashi - Nature 2025 被引用: 248

  3. Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers

    著者: Hisayuki Shigematsu, Lin Li, Tsuyoshi Takahashi, Masatoshi Nomura, M. Suzuki, I. Wistuba, Kwun M. Fong, Hai Quan Lee, Shinichi Toyooka, Nobutaka Shimizu, Takehiko Fujisawa, Ziding Feng, Jack A. Roth, Joachim Herz, J D Minna, Adi F. Gazdar - JNCI Journal of the National Cancer Institute 2005 被引用: 2,399

  4. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial

    著者: Keiju Aokage, Kenji Suzuki, Hisashi Saji, Masashi Wakabayashi, Tomoko Kataoka, Yuta Sekino, Haruhiko Fukuda, Makoto Endo, Aritoshi Hattori, Takahiro Mimae, Tomohiro Miyoshi, Mitsuhiro Isaka, Hiroshige Yoshioka, Ryu Nakajima, Kazuo Nakagawa, Jiro Okami, Hiroyuki Ito, Hiroaki Kuroda, Masahiro Tsuboi, Norihito Okumura, Makoto Takahama, Yasuhisa Ohde, Tadashi Aoki, Yasuhiro Tsutani, Morihito Okada, Shun‐ichi Watanabe, Yukinori Sakao, Sakae Okumura, Toshihiko Iizasa, Ichiro Yoshino, Atsushi Fujita, Morihito Okada, Masahiro Yoshimura, Yuji Asato, Kenji Suzuki, Haruhiko Nakayama, Isao Matsumoto, Tetsuya Mitsudomi, Takashi Marutsuka, Makoto Suzuki, Norihito Okumura, Haruhiko Kondo, Hiroshi Date, Takeshi Nagayasu, Kohei Yokoi, Shunichi Watanabe, Masahiro Tsuboi, Akihide Matsumura, Yoshinori Yamashita, Kiyoshi Ishikawa, Motohiro Yamashita, Yasuki Saito, Mitsuhiro Takenoyama, Katsuo Yoshiya, Kenji Sugio, Shinichiro Miyoshi, Makoto Takahama, Yoshihisa Kadota, Masahiko Higashiyama, Meinoshin Okumura, Hirohiko Akiyama, Akinori Iwasaki, Yasuhisa Ohde, Haruhiko Nakamura, Haruhisa Matsuguma, Takashi Kondo, Norihiko Ikeda, Hirotoshi Horio, Toru Sato, Takuya Nagashima, Akira Yoshizu, Hiromi Katsuki, Hiroaki Kuroda, Mingyon Mun, Kouhei Tajima, Wataru Nishio, Moriyuki Kiyoshima, Hiroyuki Ito, Yasuhiro Tsutani, Masashi Kobayashi, Masaki Anraku, Toyofumi Yoshikawa, Hyung-eun Yoon, Takeshi Mimura, Tsutomu Kawabata, Tohru Hasumi, Tatsuro Okamoto, Tadashi Aoki, Shinichi Toyooka, Jiro Okami, Yasushi Shintani, Tomomi Hirata, Hisashi Saji, Yoshinori Okada, Makoto Endo, Tetsukan Woo, Mai Daido - The Lancet Respiratory Medicine 2023 被引用: 227

  5. A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non–Small Cell Lung Cancer

    著者: Katsuyuki Hotta, Keisuke Aoe, Toshiyuki Kozuki, Kadoaki Ohashi, Kiichiro Ninomiya, Eiki Ichihara, Toshio Kubo, Takashi Ninomiya, Kenichi Chikamori, Daijiro Harada, Naoyuki Nogami, Taizo Hirata, Shiro Hinotsu, Shinichi Toyooka, Katsuyuki Kiura - Journal of Thoracic Oncology 2017 被引用: 175

  6. Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010

    著者: Jiro Okami, Yasushi Shintani, Meinoshin Okumura, Hiroyuki Ito, Takashi Ohtsuka, Shinichi Toyooka, Takeshi Mori, Shun‐ichi Watanabe, Hiroshi Date, Kohei Yokoi, Hisao Asamura, Takeshi Nagayasu, Etsuo Miyaoka, Ichiro Yoshino - Journal of Thoracic Oncology 2018 被引用: 217

  7. Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)

    著者: Yoichi Naito, Hiroyuki Aburatani, Toraji Amano, Eishi Baba, Toru Furukawa, Tetsu Hayashida, Eiso Hiyama, Sadakatsu Ikeda, Masashi Kanai, Motohiro Kato, Ichiro Kinoshita, Naomi Kiyota, Takashi Kohno, Shinji Kohsaka, Keigo Komine, Itaru Matsumura, Yuji Miura, Yoshiaki Nakamura, Atsushi Natsume, Kazuto Nishio, Katsutoshi Oda, N. Oda, Natsuko Okita, Kumiko Oseto, Kuniko Sunami, Hideaki Takahashi, Masayuki Takeda, S. Tashiro, Shinichi Toyooka, Hideki Ueno, Shinichi Yachida, Takayuki Yoshino, Katsuya Tsuchihara - International Journal of Clinical Oncology 2020 被引用: 103

  8. Somatic Mutations of the HER2 Kinase Domain in Lung Adenocarcinomas

    著者: Hisayuki Shigematsu, Takao Takahashi, Masaharu Nomura, Kuntal Majmudar, Makoto Suzuki, Huei Lee, Ignacio I. Wistuba, Kwun M. Fong, Shinichi Toyooka, Nobuyoshi Shimizu, Takehiko Fujisawa, John D. Minna, Adi F. Gazdar - Cancer Research 2005 被引用: 677

  9. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer

    著者: Fumiaki Takatsu, Ken Suzawa, Shuta Tomida, Yin Min Thu, Masakiyo Sakaguchi, Tomohiro Toji, Masayoshi Ohki, Shimpei Tsudaka, Keiichi Date, Naoki Matsuda, Kazuma Iwata, Yidan Zhu, Kentaro Nakata, Kazuhiko Shien, Hiromasa Yamamoto, Akiko Nakayama, Mikio Okazaki, Seiichiro Sugimoto, Shinichi Toyooka - Journal of Molecular Medicine 2023 被引用: 28

  10. Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non–Small-Cell Lung Cancer

    著者: Hirotsugu Kenmotsu, Nobuyuki Yamamoto, Takeharu Yamanaka, Katsuo Yoshiya, Toshiaki Takahashi, Tsuyoshi Ueno, Kōichi Goto, Haruko Daga, Norihiko Ikeda, Kenji Sugio, Takashi Seto, Shinichi Toyooka, Hiroshi Date, Tetsuya Mitsudomi, Isamu Okamoto, Kohei Yokoi, Hideo Saka, Hiroaki Okamoto, Yuichi Takiguchi, Masahiro Tsuboi - Journal of Clinical Oncology 2020 被引用: 114

  11. JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer

    著者: Kazuhiko Shien, Vassiliki A. Papadimitrakopoulou, Dennis Ruder, Carmen Behrens, Li Shen, Neda Kalhor, Juhee Song, J. Jack Lee, Jing Wang, Ximing Tang, Roy S. Herbst, Shinichi Toyooka, Luc Girard, John D. Minna, Jonathan M. Kurie, Ignacio I. Wistuba, Julie Izzo - Molecular Cancer Therapeutics 2017 被引用: 103

  12. Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1

    著者: Kadoaki Ohashi, Lecia V. Sequist, Maria E. Arcila, Teresa Morán, Juliann Chmielecki, Ya-Lun Lin, Yumei Pan, Lu Wang, Elisa de Stanchina, Kazuhiko Shien, Keisuke Aoe, Shinichi Toyooka, Katsuyuki Kiura, Lynnette Fernandez‐Cuesta, Panos Fidias, James Chih‐Hsin Yang, Vincent A. Miller, Gregory J. Riely, Mark G. Kris, Jeffrey A. Engelman, Cindy L. Vnencak‐Jones, Dora Dias‐Santagata, Marc Ladanyi, William Pao - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 437

  13. Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations

    著者: Adi Gazdar, Linda Robinson, Dwight Oliver, Chao Xing, William D. Travis, Junichi Soh, Shinichi Toyooka, Lori Watumull, Yang Xie, Kemp H. Kernstine, Joan H. Schiller - Journal of Thoracic Oncology 2014 被引用: 153

  14. Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR -Mutant Non–Small Cell Lung Cancer Cells

    著者: Kei Namba, Kazuhiko Shien, Yuta Takahashi, Hidejiro Torigoe, Hiroki Sato, Takahiro Yoshioka, Tatsuaki Takeda, Eisuke Kurihara, Yusuke Ogoshi, Hiromasa Yamamoto, Junichi Soh, Shuta Tomida, Shinichi Toyooka - Molecular Cancer Research 2018 被引用: 94

  15. DV200 Index for Assessing RNA Integrity in Next‐Generation Sequencing

    著者: Takehiro Matsubara, Junichi Soh, Mizuki Morita, Takahiro Uwabo, Shuta Tomida, Toshiyoshi Fujiwara, Susumu Kanazawa, Shinichi Toyooka, Akira Hirasawa - BioMed Research International 2020 被引用: 91

  16. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis

    著者: Kota Araki, Rie Kinoshita, Nahoko Tomonobu, Yuma Gohara, Shuta Tomida, Yuta Takahashi, Satoru Senoo, Akihiko Taniguchi, Junko Itano, Ken-ichi Yamamoto, Hitoshi Murata, Ken Suzawa, Kazuhiko Shien, Hiromasa Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Kouichi Ichimura, Masahiro Nishibori, Nobuaki Miyahara, Shinichi Toyooka, Masakiyo Sakaguchi - Journal of Molecular Medicine 2020 被引用: 67

  17. EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey

    著者: Yasushi Yatabe, Keith M. Kerr, Ahmad Rusdan Handoyo Utomo, Pathmanathan Rajadurai, Văn Khanh Trần, Xiang Du, Teh‐Ying Chou, Ma. Luisa D. Enriquez, Geon Kook Lee, Jabed Iqbal, Shanop Shuangshoti, Jin-Haeng Chung, Koichi Hagiwara, Zhiyong Liang, Nicola Normanno, Keunchil Park, Shinichi Toyooka, Chun‐Ming Tsai, Paul Waring, Li Zhang, Rose McCormack, M. Ratcliffe, Y. Itoh, Masatoshi Sugeno, Tony Mok - Journal of Thoracic Oncology 2014 被引用: 187

  18. Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast

    著者: Kosuke Ochi, Ken Suzawa, Yin Min Thu, Fumiaki Takatsu, Shimpei Tsudaka, Yidan Zhu, Kentaro Nakata, Tatsuaki Takeda, Kazuhiko Shien, Hiromasa Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Tadahiko Shien, Yoshiharu Okamoto, Shuta Tomida, Shinichi Toyooka - Cancer Science 2022 被引用: 24

  19. PIK3CA Mutations and Copy Number Gains in Human Lung Cancers

    著者: Hiromasa Yamamoto, Hisayuki Shigematsu, Masaharu Nomura, William W. Lockwood, Mitsuo Sato, Naoki Okumura, Junichi Soh, Makoto Suzuki, Ignacio I. Wistuba, Kwun M. Fong, Huei Lee, Shinichi Toyooka, Hiroshi Date, Wan L. Lam, John D. Minna, Adi F. Gazdar - Cancer Research 2008 被引用: 432

  20. Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases

    著者: Kenichi Suda, Tetsuya Mitsudomi, Yasushi Shintani, Jiro Okami, Hiroyuki Ito, Takashi Ohtsuka, Shinichi Toyooka, Takeshi Mori, Shun‐ichi Watanabe, Hisao Asamura, Masayuki Chida, Hiroshi Date, Shunsuke Endo, Takeshi Nagayasu, Ryoichi Nakanishi, Etsuo Miyaoka, Meinoshin Okumura, Ichiro Yoshino - The Annals of Thoracic Surgery 2020 被引用: 122

  21. Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression

    著者: David G. Burbee, Éva Forgács, Sabine Zöchbauer‐Müller, Latha Shivakumar, Kwun M. Fong, Bo Gao, Dwight E. Randle, Masashi Kondo, A K Virmani, S. Bader, Yoshitaka Sekido, Farida Latif, Sara Milchgrub, Shinichi Toyooka, Adi F. Gazdar, M.I. Lerman, Eugene R. Zabarovsky, Michael A. White, J D Minna - JNCI Journal of the National Cancer Institute 2001 被引用: 771

  22. Presence ofEpidermal Growth Factor ReceptorGene T790M Mutation as a Minor Clone in Non–Small Cell Lung Cancer

    著者: Michio Inukai, Shinichi Toyooka, Sachio Ito, Hiroaki Asano, Shuji Ichihara, Junichi Soh, Hiroshi Suehisa, Mamoru Ouchida, Keisuke Aoe, Motoi Aoe, Katsuyuki Kiura, Nobuyoshi Shimizu, Hiroshi Date - Cancer Research 2006 被引用: 447

  23. CT Fluoroscopy-Guided Biopsy of 1,000 Pulmonary Lesions Performed With 20-Gauge Coaxial Cutting Needles

    著者: Takao Hiraki, Hidefumi Mimura, Hideo Gobara, Toshihiro Iguchi, Hiroyasu Fujiwara, Jun Sakùrai, Yusuke Matsui, Daisaku Inoue, Shinichi Toyooka, Yoshifumi Sano, Susumu Kanazawa - CHEST Journal 2009 被引用: 212

  24. Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer

    著者: Hiroshige Yoshioka, Mototsugu Shimokawa, Takashi Seto, Satoshi Morita, Yasushi Yatabe, Isamu Okamoto, Junji Tsurutani, Miyako Satouchi, T. Hirashima, Shinji Atagi, Kazuhiko Shibata, Hiroshi Saito, Shinichi Toyooka, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Tetsuya Mitsudomi - Annals of Oncology 2019 被引用: 91